Table 2.
Characteristics of patients
| Sample ID | Age | Sex | Diagnosis | Sample ID | Age | Sex | Diagnosis |
|---|---|---|---|---|---|---|---|
| MS 02–02 | 38 | M | RRMS | MS 03–13 | 45 | F | RRMS |
| MS 02–06 | 42 | F | RRMS | MS 04–01 | 42 | F | RRMS |
| MS 02–07 | 54 | F | RRMS | MS 04–03 | 44 | M | RRMS |
| MS 02–08 | 30 | F | RRMS | MS 04–04 | 31 | F | RRMS |
| MS 02–10 | 45 | F | RRMS | MS 04–05 | 56 | F | RRMS |
| MS 02–11 | 22 | F | RRMS | MS 04–06 | 30 | M | RRMS |
| MS 02–14 | 51 | F | RRMS | MS 04–07 | 56 | F | PPMS |
| MS 02–15 | 26 | F | RRMS | MS 04–08 | 28 | F | RRMS |
| MS 02–16 | 48 | F | RRMS | MS 04–09 | 48 | M | RRMS |
| MS 02–17 | 33 | F | RRMS | MS 05–01 | 52 | M | RRMS |
| MS 02–18 | 41 | F | RRMS | MS 05–02 | 53 | F | RRMS |
| MS 02–21 | 54 | F | RRMS | MS 05–03 | 30 | F | RRMS |
| MS 02–22 | 49 | F | RRMS | MS 05–04 | 57 | F | RRMS |
| MS 02–24 | 39 | F | SPMS | MS 05–05 | 53 | M | RRMS |
| MS 03–01 | 25 | F | RRMS | MS 05–06 | 62 | M | PPMS |
| MS 03–02 | 49 | F | RRMS | MS 05–07 | 40 | M | RRMS |
| MS 03–03 | 50 | M | RRMS | MS 05–08 | 46 | F | RRMS |
| MS 03–04 | 22 | F | RRMS | MS 05–10 | 61 | F | RRMS |
| MS 03–05 | 51 | F | RRMS | MS 06–01 | 65 | M | RRMS |
| MS 03–07 | 42 | F | RRMS | IC 06–01 | 66 | M | SSPE* |
| MS 03–08 | 48 | F | RRMS | IC 06–02 | 36 | F | SSPE |
| MS 03–09 | 40 | F | RRMS | IC 04–01 | 39 | F | Behcet’s disease |
| MS 03–10 | 45 | F | RRMS | IC 04–05 | 57 | M | Cryptococcal meningtitis |
| MS 03–11 | 47 | F | RRMS | IC 07–02 | 49 | M | Viral meningitis |
*SSPE: Subacute sclerosing panencephalitis